Bokus

Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation – författare

Visar alla böcker från författaren Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation. Handla med fri frakt och snabb leverans.

2 produkter

  1. Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation, and Economic Policy Board on Science, Technology, and Law Committee on Science, Technology, Policy and Global Affairs, National Research Council, Stephen A. Merrill, Anne-Marie Mazza - Reaping the Benefits of Genomic and Proteomic Research, E-bok. Tillgänglighet: Lägg i varukorg

    Reaping the Benefits of Genomic and Proteomic Research

    Intellectual Property Rights, Innovation, and Public Health

    Av Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation, and Economic Policy Board on Science, Technology m. fl.

    E-bok, 2006

    746 kr

    Lägg i varukorg

    The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP …

  2. Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation, and Economic Policy Board on Science, Technology, and Law Committee on Science, Technology, Policy and Global Affairs, National Research Council, Stephen A. Merrill, Anne-Marie Mazza - Reaping the Benefits of Genomic and Proteomic Research, E-bok. Tillgänglighet: Lägg i varukorg

    Reaping the Benefits of Genomic and Proteomic Research

    Intellectual Property Rights, Innovation, and Public Health

    Av Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation, and Economic Policy Board on Science, Technology m. fl.

    E-bok, 2006

    572 kr

    Lägg i varukorg

    The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP …